NR 565 advanced pharmacology FINAL -
Chamberlain Practice EXAM EXAM
GUIDE 2026/2027 | COMPLETE REVIEW |
FINAL EXAM | MIDTERM EXAM |
PRACTICE TEST | ACCURATE
QUESTIONS & DETAILED ANSWERS |
LATEST UPDATED VERSION
Description
Prepare for success with this comprehensive Exam Guide 2026/2027, created to help students
confidently prepare for exams and achieve excellent results. This study resource includes
carefully selected exam-style questions, correct answers, and detailed explanations covering the
most important course concepts. It is ideal for reviewing key topics, strengthening
understanding, and improving overall exam performance.
Perfect for Final Exams, Midterm Exams, Unit Tests, Weekly Quizzes, Practice Tests,
Comprehensive Assessments, Exit Exams, Certification Exams, and course revision. This
guide is organized in an easy-to-follow format, making it an excellent resource for self-study,
last-minute revision, and academic success.
Features
Latest 2026/2027 Updated Content
Accurate Exam-Style Questions
Correct & Detailed Answers
Comprehensive Topic Review
Step-by-Step Explanations
Easy-to-Understand Format
Excellent for Self-Study & Revision
High-Quality Study Resource
,Keywords
Exam Guide, Study Guide, Final Exam, Midterm Exam, Practice Test, Practice Questions, Test
Bank, Question Bank, Exam Review, Course Review, Unit Test, Weekly Quiz, Assessment,
Comprehensive Exam, Certification Exam, Exit Exam, Study Notes, Revision Notes, Answer
Key, Detailed Solutions, Exam Preparation, College Exam, University Exam, Learning
In which patient population is Metformin contraindicated in?
A. Diabetics with HA1c < 7.0%
B. Patients older than 50
C. Alcoholics
D. Women suffering from infertility
C. Alcoholics
What lab value suggests metformin might be contraindicated?
A. eGFR <30
B. Crea 0.8
C. WBC 7.8
D. Bun 17
A. eGFR <30
What medication is contraindicated to treat diabetes if a patient already has a
cardiac ejection fraction rate of 40%?
A. Second Generation sulfonyureas
B. Thiazolidinediones
C. Dopamine Agonist
D. Glucosidase Inhibitor
B. Thiazolidinediones
Sabrina is a 35-year-old female who presents with complaints of fatigue, anxiety,
and palpitations. She has a long history of obesity and reports that she is happy
that she has lost 23 pounds in the last 2 months. She also reports that she has
trouble sleeping and her husband complains that she is keeping the house too
cold. Physical exam reveals slight tachycardia at 104 bpm and a slightly enlarged
thyroid. Thyroid testing reveals hyperthyroidism or Grave's disease.
Which of the following agents is the first-line treatment for hyperthyroidism or
Grave's disease?
A. Methimazole
B. Metoprolol
C. Allopurinol
D. Levothyroxine
A. Methimazole
, Which of the following medications would be considered the first line of
treatment for a newly diagnosed Diabetic patient with adequate renal and hepatic
function?
A: NovoLog Sliding Scale Insulin
B: Liraglutide (Victoza)
C: Oral Metformin
D: Glipizide
C: Oral Metformin
Of the following medications, which is most likely to cause hypoglycemia?
A. Metformin
B. Insulin
C. Incretin mimetics
D. Thiazolidinediones
B. Insulin
Which symptoms are most expected of a patient diagnosed with hypothyroidism?
A. shortness of breath, wheezing, fatigue
B. tachycardia, insomnia, weight loss, goiter
C. irritability, anxiety, dizziness, increased sweating
D. dry pale skin, brittle hair, fatigue, myxedema
D. dry skin, brittle hair, fatigue, myxedema
Patients with an increased risk for UTIs and genital infections or an active
diagnosis, should avoid what drug class/es for treatment of Type II Diabetes?
A. Thiazolidinediones (Glitazones)
B. Biguanide.
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
D. All of the above.
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
A 45-year-old patient with a history of type 2 diabetes presents to the clinic for a
follow-up appointment. The healthcare provider has prescribed metformin as part
of the treatment plan. Which of the following statements regarding metformin is
correct?
A. Metformin primarily stimulates insulin production from the pancreas.
B. Metformin reduces glucose levels primarily by decreasing insulin resistance.
C. Metformin is associated with a risk of hypoglycemia.
D. Metformin improves insulin sensitivity and reduces hepatic glucose
production.
D. Metformin improves insulin sensitivity and reduces hepatic glucose production.
In what part of the body are SGLT-2 (sodium-glucose cotransporter 2) inhibitors
active?
A. Small intestine
Chamberlain Practice EXAM EXAM
GUIDE 2026/2027 | COMPLETE REVIEW |
FINAL EXAM | MIDTERM EXAM |
PRACTICE TEST | ACCURATE
QUESTIONS & DETAILED ANSWERS |
LATEST UPDATED VERSION
Description
Prepare for success with this comprehensive Exam Guide 2026/2027, created to help students
confidently prepare for exams and achieve excellent results. This study resource includes
carefully selected exam-style questions, correct answers, and detailed explanations covering the
most important course concepts. It is ideal for reviewing key topics, strengthening
understanding, and improving overall exam performance.
Perfect for Final Exams, Midterm Exams, Unit Tests, Weekly Quizzes, Practice Tests,
Comprehensive Assessments, Exit Exams, Certification Exams, and course revision. This
guide is organized in an easy-to-follow format, making it an excellent resource for self-study,
last-minute revision, and academic success.
Features
Latest 2026/2027 Updated Content
Accurate Exam-Style Questions
Correct & Detailed Answers
Comprehensive Topic Review
Step-by-Step Explanations
Easy-to-Understand Format
Excellent for Self-Study & Revision
High-Quality Study Resource
,Keywords
Exam Guide, Study Guide, Final Exam, Midterm Exam, Practice Test, Practice Questions, Test
Bank, Question Bank, Exam Review, Course Review, Unit Test, Weekly Quiz, Assessment,
Comprehensive Exam, Certification Exam, Exit Exam, Study Notes, Revision Notes, Answer
Key, Detailed Solutions, Exam Preparation, College Exam, University Exam, Learning
In which patient population is Metformin contraindicated in?
A. Diabetics with HA1c < 7.0%
B. Patients older than 50
C. Alcoholics
D. Women suffering from infertility
C. Alcoholics
What lab value suggests metformin might be contraindicated?
A. eGFR <30
B. Crea 0.8
C. WBC 7.8
D. Bun 17
A. eGFR <30
What medication is contraindicated to treat diabetes if a patient already has a
cardiac ejection fraction rate of 40%?
A. Second Generation sulfonyureas
B. Thiazolidinediones
C. Dopamine Agonist
D. Glucosidase Inhibitor
B. Thiazolidinediones
Sabrina is a 35-year-old female who presents with complaints of fatigue, anxiety,
and palpitations. She has a long history of obesity and reports that she is happy
that she has lost 23 pounds in the last 2 months. She also reports that she has
trouble sleeping and her husband complains that she is keeping the house too
cold. Physical exam reveals slight tachycardia at 104 bpm and a slightly enlarged
thyroid. Thyroid testing reveals hyperthyroidism or Grave's disease.
Which of the following agents is the first-line treatment for hyperthyroidism or
Grave's disease?
A. Methimazole
B. Metoprolol
C. Allopurinol
D. Levothyroxine
A. Methimazole
, Which of the following medications would be considered the first line of
treatment for a newly diagnosed Diabetic patient with adequate renal and hepatic
function?
A: NovoLog Sliding Scale Insulin
B: Liraglutide (Victoza)
C: Oral Metformin
D: Glipizide
C: Oral Metformin
Of the following medications, which is most likely to cause hypoglycemia?
A. Metformin
B. Insulin
C. Incretin mimetics
D. Thiazolidinediones
B. Insulin
Which symptoms are most expected of a patient diagnosed with hypothyroidism?
A. shortness of breath, wheezing, fatigue
B. tachycardia, insomnia, weight loss, goiter
C. irritability, anxiety, dizziness, increased sweating
D. dry pale skin, brittle hair, fatigue, myxedema
D. dry skin, brittle hair, fatigue, myxedema
Patients with an increased risk for UTIs and genital infections or an active
diagnosis, should avoid what drug class/es for treatment of Type II Diabetes?
A. Thiazolidinediones (Glitazones)
B. Biguanide.
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
D. All of the above.
C. Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
A 45-year-old patient with a history of type 2 diabetes presents to the clinic for a
follow-up appointment. The healthcare provider has prescribed metformin as part
of the treatment plan. Which of the following statements regarding metformin is
correct?
A. Metformin primarily stimulates insulin production from the pancreas.
B. Metformin reduces glucose levels primarily by decreasing insulin resistance.
C. Metformin is associated with a risk of hypoglycemia.
D. Metformin improves insulin sensitivity and reduces hepatic glucose
production.
D. Metformin improves insulin sensitivity and reduces hepatic glucose production.
In what part of the body are SGLT-2 (sodium-glucose cotransporter 2) inhibitors
active?
A. Small intestine
